Low-risk prostate cancer: biennial biopsy is an acceptable option

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • The risk for upgrading varied in the 4 international active surveillance cohorts even after adjustments for surveillance intervals and competing treatments.
  • Biennial biopsies may reduce the number of biopsies without significant delay in detecting upgraded cancer.

Why this ma...